|
ARV drugs
|
Stock-out days of ARVs within 6 months prior to the study
|
Percentage difference between ordered and received quantities of ARVS
|
|---|
|
Health centers
|
Hospitals
|
Health centers
|
Hospitals
|
|---|
|
Average number of days ± SD
|
Average number of days ± SD
|
Mean percentage difference ± SD
|
(Min, Max)
|
Mean percentage difference ± SD
|
(min, max)
|
|---|
|
EFV50
|
12 ± 21
|
0
|
0
|
0
|
a
|
a
|
|
EFV200
|
10.1 ± 28
|
0
|
9.5 ± 21.2
|
(0, 47.6)
|
0
|
0
|
|
EFV600
|
18.8 ± 25
|
0
|
47 ± 32.3
|
(0, 80.7)
|
2.9 ± 2.7
|
(0, 11.5)
|
|
3TC300/TDF300
|
45.9 ± 45.5
|
42.5 ± 60.1
|
51.7 ± 33.8
|
(0, 99)
|
69.6 ± 17
|
(55, 93.4)
|
|
NVP 200
|
16.6 ± 30.8
|
36.5 ± 19.1
|
0
|
0
|
0
|
0
|
|
ZDV300/3TC150
|
9.7 ± 13.9
|
34.5 ± 14.8
|
27.1 ± 43.1
|
(0, 143)
|
34 ± 29.5
|
(0, 52)
|
|
ZDV300/3TC150/NVP200
|
13 ± 19.9
|
20.5 ± 4.9
|
14.8 ± 33.6
|
(0, 93.6)
|
50 ± 0
|
(50,50)
|
|
3TC30/ZDV60/NVP50
|
15 ± 17
|
0
|
0
|
0
|
0
|
0
|
|
NVP 240 ml
|
33.7 ± 46.7
|
29 ± 41
|
5.9 ± 16.6
|
(0, 47.1)
|
0
|
0
|
|
D4T12/3TC60/NVP100
|
20.1 ± 25
|
27 ± 0.0
|
27.8 ± 83.5
|
(0, 290)
|
0
|
0
|
|
D4T6/3TC30/NVP50
|
16.8 ± 24.4
|
0
|
110.8 ± 193.8
|
(0, 400)
|
0
|
0
|
|
3TC30/ZDV60
|
14.8 ± 21.8
|
16.5 ± 14.8
|
25.4 ± 35.9
|
(0, 50.8)
|
45.7 ± 12.7
|
(36.7,54.7)
|
|
D4T 12/3TC60
|
15.6 ± 33.1
|
0
|
0
|
0
|
69.4 ± 33.3
|
(45.8,93)
|
|
D4T 6/3TC30
|
55.8 ± 45
|
0
|
a
|
a
|
0
|
0
|
-
ameans the product was not ordered by the health facility in last requisition and reporting reviewed
-
D4T = Stavudine; EFV = Efavernez; NVP = Nevirapine; TDF = Tenofovir; 3TC = Lamivudine; ZDV = Zidovudine
